S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
Log in

U.S. Physical Therapy Stock Price, News & Analysis (NYSE:USPH)

$133.85
+0.07 (+0.05 %)
(As of 10/16/2019 04:00 PM ET)
Today's Range
$132.74
Now: $133.85
$135.43
50-Day Range
$127.06
MA: $131.96
$137.99
52-Week Range
$98.69
Now: $133.85
$138.58
Volume93,209 shs
Average Volume73,332 shs
Market Capitalization$1.71 billion
P/E Ratio50.51
Dividend Yield0.91%
Beta1.12
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors As of March 14, 2019, it operated 592 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. Read More…

Industry, Sector and Symbol

Industry Health services
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP90337L10
Phone713-297-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$453.91 million
Cash Flow$3.48 per share
Book Value$17.10 per share

Profitability

Net Income$34.87 million

Miscellaneous

Employees4,600
Market Cap$1.71 billion
Next Earnings Date11/7/2019 (Confirmed)
OptionableOptionable

Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.


U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Wednesday, July 3rd. Investors of record on Thursday, August 15th will be paid a dividend of $0.30 per share on Friday, September 13th. This represents a $1.20 dividend on an annualized basis and a yield of 0.90%. The ex-dividend date is Wednesday, August 14th. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.27. View U.S. Physical Therapy's Dividend History.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) posted its quarterly earnings results on Thursday, August, 8th. The company reported $0.81 earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of $0.81. The company earned $126.40 million during the quarter, compared to analysts' expectations of $124.86 million. U.S. Physical Therapy had a net margin of 6.22% and a return on equity of 19.19%. The company's revenue for the quarter was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.73 earnings per share. View U.S. Physical Therapy's Earnings History.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release their next quarterly earnings announcement on Thursday, November 7th 2019. View Earnings Estimates for U.S. Physical Therapy.

How can I listen to U.S. Physical Therapy's earnings call?

U.S. Physical Therapy will be holding an earnings conference call on Thursday, November 7th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has U.S. Physical Therapy issued on next quarter's earnings?

U.S. Physical Therapy updated its FY19 earnings guidance on Thursday, August, 8th. The company provided EPS guidance of $2.87-2.97 for the period, compared to the Thomson Reuters consensus estimate of $2.93.

What price target have analysts set for USPH?

3 Wall Street analysts have issued 12-month price targets for U.S. Physical Therapy's shares. Their predictions range from $106.61 to $107.00. On average, they anticipate U.S. Physical Therapy's stock price to reach $106.81 in the next twelve months. This suggests that the stock has a possible downside of 20.2%. View Analyst Price Targets for U.S. Physical Therapy.

What is the consensus analysts' recommendation for U.S. Physical Therapy?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for U.S. Physical Therapy.

What are Wall Street analysts saying about U.S. Physical Therapy stock?

Here are some recent quotes from research analysts about U.S. Physical Therapy stock:
  • 1. According to Zacks Investment Research, "U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders. " (10/5/2019)
  • 2. Barrington Research analysts commented, "We think this guidance is likely conservative and would not be surprised to see the adjusted EPS guidance increase as early as next quarter. Our current adjusted EPS expectation is $2.92." (5/3/2019)

Has U.S. Physical Therapy been receiving favorable news coverage?

News articles about USPH stock have been trending positive recently, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. U.S. Physical Therapy earned a daily sentiment score of 2.1 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for U.S. Physical Therapy.

Who are some of U.S. Physical Therapy's key competitors?

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Synergy Pharmaceuticals (SGYP), Allergan (AGN), Qorvo (QRVO), Yandex (YNDX), Baxter International (BAX), Cleveland-Cliffs (CLF), Booking (BKNG), BioMarin Pharmaceutical (BMRN), Gilead Sciences (GILD) and Illumina (ILMN).

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the folowing people:
  • Mr. Christopher J. Reading, Pres, CEO & Director (Age 55)
  • Mr. Lawrance W. McAfee, Exec. VP, CFO & Director (Age 64)
  • Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 62)
  • Mr. Graham Reeve M.B.A., P.T., Chief Operating Officer of East (Age 55)
  • Mr. Jon C. Bates, VP & Corp. Controller

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (2.98%), Scout Investments Inc. (0.76%), State of Alaska Department of Revenue (0.08%) and Campbell & CO Investment Adviser LLC (0.02%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Jerald L Pullins, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson. View Institutional Ownership Trends for U.S. Physical Therapy.

Which major investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc. and Riverbridge Partners LLC. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Lawrance W Mcafee and Mark J Brookner. View Insider Buying and Selling for U.S. Physical Therapy.

Which major investors are buying U.S. Physical Therapy stock?

USPH stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue and Campbell & CO Investment Adviser LLC. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin and Regg E Swanson. View Insider Buying and Selling for U.S. Physical Therapy.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $133.85.

How big of a company is U.S. Physical Therapy?

U.S. Physical Therapy has a market capitalization of $1.71 billion and generates $453.91 million in revenue each year. The company earns $34.87 million in net income (profit) each year or $2.65 on an earnings per share basis. U.S. Physical Therapy employs 4,600 workers across the globe.View Additional Information About U.S. Physical Therapy.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is http://www.usph.com/.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]


MarketBeat Community Rating for U.S. Physical Therapy (NYSE USPH)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  192 (Vote Outperform)
Underperform Votes:  283 (Vote Underperform)
Total Votes:  475
MarketBeat's community ratings are surveys of what our community members think about U.S. Physical Therapy and other stocks. Vote "Outperform" if you believe USPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: S&P 500 Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel